Svanvid Sp. z o. o. is a pioneering biotechnology company that uses Swedish Know-How every day. We have been dealing with the production of active and natural raw materials for years, which are used in the pharmaceutical industry. As a result of advanced and long-term research, we have developed several dozen production methods - ultra-clean, natural and innovative products that build our clients' business every day.
72.11.Z - Scientific research and development activities
10 - Manufacture of food products
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
28 - Manufacture of machines and equipment not elsewhere classified
33 - Repair, maintenance, and installation of machinery and equipment
46 - Wholesale trade
47 - Retail trade
74 - Other professional, scientific and technical activities
85 - Education
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -6,4 | -2,1 | -9,4 | -354,8 |
EBITDA | -6,3 | -30,9 | ||
Short time liabilities | 4,6 | 437,6 | ||
Income tax | 0 | 0 | 0 | |
Equity capital | 3,7 | 1,6 | -7,8 | -576,1 |
Operating profit (EBIT) | -6,3 | 84,1 | ||
Assets | 8,3 | 8,6 | 0 | -100 |
Net profit (loss) | -6,4 | -2,1 | -9,4 | -354,8 |
Cash | 0,4 | -95,3 | ||
Net income from sale | 0 | 0 | ||
Liabilities and provisions for liabilities | 4,6 | 7 | 7,8 | 11,8 |
Working assets | 8,3 | 8,6 | 0 | -100 |
Basic operational activity income | 0 | 0 | 0 | |
Depreciation | 0 | -100 | ||
% | % | % | p.p. | |
Profitability of capital | -172,6 | -126,7 | 45,9 | |
Equity capital to total assets | 44,6 | 19 | -25,6 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 0 | ||
Current financial liquidity indicator | 1.8059866428375244 | -11 | ||
Net dept to EBITDA | -0.4166242778301239 | -2,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane